SCHEMBL8675657

SCHEMBL8675657

Nc1c(Br)cc2c(c1[N+](=O)[O-])CC(N1CCCC1)C2

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FYN P06241 1/20 0.37
MAPT P10636 5/20 0.34
ALDH1A1 P00352 4/20 0.34
CYP3A4 P08684 1/20 0.34
PKM P14618 1/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
MAPK1 P28482 1/20 0.33
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CTSB P07858 1/20 0.31
L3MBTL3 Q96JM7 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
LMNA P02545 2/20 0.31
NPC1 O15118 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8668680 0.99 FYN (0.39) FYNMAPTALDH1A1CYP3A4PKM
SCHEMBL8669857 0.78 ALDH1A1 (0.39) FYNMAPTALDH1A1CYP3A4CTSB
SCHEMBL8669853 0.78 ALDH1A1 (0.39) FYNMAPTALDH1A1CYP3A4CTSB
SCHEMBL8671076 0.78 ALDH1A1 (0.39) FYNMAPTALDH1A1CYP3A4CTSB
Hydrochloric Acid SCHEMBL8668055 0.77 ALDH1A1 (0.38) FYNMAPTALDH1A1CYP3A4CTSB
SCHEMBL8669254 0.74 THRA (0.38) ALDH1A1CYP3A4CYP1A2CTSBLMNA
SCHEMBL21962340 0.72 GRIN1 (0.48) MAPTALDH1A1CYP3A4CTSB
SCHEMBL8668636 0.70 CA1 (0.44) ALDH1A1CYP3A4
Hydrochloric Acid SCHEMBL8671380 0.70 MAPT (0.38) MAPTALDH1A1CYP3A4PKMMEN1
SCHEMBL8702721 0.69 ALDH1A1 (0.32) ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5721234-A TREATING CONVULSIONS, ANXIETY, CEREBRAL HYPOXIA/ISCHEMIA, PARKINSON*S DISEASE WARNER-LAMBERT COMPANY (US) 1998-02-24 US disclosed
WO-1996017832-A1 NOVEL GLUTAMATE RECEPTOR ANTAGONISTS: FUSED CYCLOALKYLQUINOXALINEDIONES WARNER-LAMBERT COMPANY (US) 1996-06-13 WO disclosed